Journals / Türkiye Diyabet ve Obezite Dergisi / 2018 / Cilt: 2 - Sayı: 3

A Case of Severe Hypertrigliseridemia Presentation with Eruptive Xantoma in an Adult with Type-2 Diabetes Mellitus and Obesity

Eruptif Ksantomla Ortaya Çıkan Tip 2 Diabetes Mellitus ve Obeziteli Bir Ağır Hipertrigliseridemi Olgusu

Pages
125–128
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In such cases, effective results can be obtained with a multifaceted approach to metabolic pathways without requiring lipid apheresis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypertriglyceridemia occurs as genetic lipid disorders with the exception of secondary causes such as obesity and hypothyroidism.
📊
Key Findings & Data:Although there are different clinical presentations, hypertriglyceridemia cases are rarely seen in adulthood with the presence of eruptive xanthoma.
💡
Conclusion & Impact:In such cases, effective results can be obtained with a multifaceted approach to metabolic pathways without requiring lipid apheresis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Eruptif Ksantom · Hiperlipidemi · Hipertrigliseridemi

Abstract

Hypertriglyceridemia occurs as genetic lipid disorders with the exception of secondary causes such as obesity and hypothyroidism. Although there are different clinical presentations, hypertriglyceridemia cases are rarely seen in adulthood with the presence of eruptive xanthoma. Here, we present a case with schizophrenia diagnosed with skin rashes and diabetes mellitus and severe hypertriglyceridemia. As seen in our case, hyperlipidemias may occur with obesity, diabetes mellitus and antipsychotics in individuals with genetic background. Their presentation may be in the form of eruptive xanthomas, a rare finding. In such cases, effective results can be obtained with a multifaceted approach to metabolic pathways without requiring lipid apheresis.

Özet

Hipertrigliseridemi, obezite ve hipotiroidizm gibi sekonder nedenler haricinde genetik lipid bozuklukları şeklinde ortaya çıkmaktadır. Farklı klinik prezantasyonları bulunmasına rağmen erişkin dönemde nadiren eruptif ksantom bulgusuyla hipertrigliseridemi olguları tanı alır. Burada, şizofreni tanısıyla izlenirken ciltte döküntüleriyle birlikte diabetes mellitus ve tip 5 hiper trigliseridemisi tanısı alan bir olguyu sunmaktayız.

🔖

Cite This Article

BAYRAKTAROĞLU, T., ALPAĞUT, A., KOCA, R., ÇAKMAK, N. D., AYHAN, İ. (2022). A Case of Severe Hypertrigliseridemia Presentation with Eruptive Xantoma in an Adult with Type-2 Diabetes Mellitus and Obesity. Türkiye Diyabet ve Obezite Dergisi, Cilt: 2 - Sayı: 3, 125–128. https://ajindex.com/articles/627961

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Kushner PA, Cobble ME.Hypertriglyceridemia: the importance of identifying patients at risk. Postgrad Med. 2016;128(8):848-858.
  2. Fredrickson DS, Lee RS. A system for phenotyping hyperlipidemia. Circulation 1965;31:321-7. Ginsberg Hn. Diabetic Dyslipidemia: Basic Mechanisms Underlying The Common Hypertriglyceridemia And Low Hdl Cholesterol Levels. Diabetes. 1996; 45(Suppl 3):S27–S30. Zaremba J. Zackiewicz A, Placek W. Eruptive xanthomas. Postep Derm Alergol 2013;30(6):399-402.
  3. Bito T, Kawakami C, Shimajiri S, Tokura Y. Generalized eruptive xanthoma with prominent deposition of naked chylomicrons: evidence for chylomicrons as the origin of urate-like crystals. J Cutan Pathol. 2010;37:1161-3.
  4. Henning JS, Fazio MG. Yellowish papules on a middle-aged man. Eruptive xanthoma. Am Fam Physician. 2011;83:73-4.
  5. Ladizinski B, Lee KC. Eruptive xanthomas in a patient with severe hypertriglyceridemia and type 2 diabetes. CMAJ. 2013;185:1600. Vangara SS, Klingbeil KD, Fertig RM, Radick JL. Severe hypertriglyceridemia presenting as eruptive xanthomatosis. J Family Med Prim Care. 2018;7(1):267-270. Kayaalp O. Hipolipidemik İlaçlar: Kayaalp O, ed. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. Ankara, Hacettepe TAŞ Kitapçılık Ltd Şti, 2000: 1. cilt, 8.baskı, 567- 587. Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, et al. The polygenic nature of hypertriglyceridaemia: Implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol. 2014;2:655–66.
  6. Valdivielso P, Ramírez-Bueno A, Ewald N. Current knowledge of hypertriglyceridemic pancreatitis. Eur J Intern Med. 2014;25:689–94